Targeting nucleophosmin 1 represents a rational strategy for radiation sensitization

Area of Science:

• Oncology
• Molecular Biology
• Radiation Oncology

Background:

• Nucleophosmin 1 (NPM1) plays a crucial role in cellular stress response and DNA repair.
• Understanding NPM1's function is key to developing novel cancer treatment strategies.
• Radiosensitization aims to enhance the efficacy of radiation therapy in cancer treatment.

Purpose of the Study:

• To investigate if targeting NPM1 with the small molecule YTR107 can radiosensitize cancer cells.
• To determine the dependency of YTR107-mediated radiosensitization on NPM1.
• To evaluate the potential of NPM1 targeting in non-small-cell lung cancer (NSCLC).

Main Methods:

• Utilized NPM1-deficient mouse embryo fibroblasts (MEFs) to assess radiosensitization.
• Quantified DNA double-strand break (DSB) repair markers (pNPM1, γH2AX, Rad51 foci) and neutral comet assay.
• Analyzed NPM1 expression in NSCLC patient samples and assessed YTR107 efficacy in NSCLC cell lines and xenografts.

Main Results:

• NPM1 is essential for DNA DSB repair; its absence increases radiation sensitivity.
• YTR107 inhibits NPM1 oligomerization and disrupts the formation of irradiation-induced foci.
• NPM1 is overexpressed in a subset of NSCLC, and YTR107 effectively radiosensitized NSCLC models.

Conclusions:

• Targeting NPM1 with YTR107 impairs DNA DSB repair, leading to increased radiation sensitivity.
• YTR107 demonstrates potential as a radiosensitizing agent, particularly in NPM1-overexpressing NSCLC.
• These findings support NPM1 as a viable target for enhancing radiation therapy efficacy.